Anterix Inc. (NASDAQ:ATEX – Get Free Report) insider Gena Ashe sold 4,357 shares of Anterix stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $85.44, for a total value of $372,262.08. Following the completion of the sale, the insider directly owned 5,174 shares in the company, valued at approximately $442,066.56. The trade was a 45.71% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Anterix Stock Performance
NASDAQ ATEX opened at $82.79 on Friday. The company has a market capitalization of $1.62 billion, a P/E ratio of 23.65 and a beta of 0.84. Anterix Inc. has a one year low of $17.58 and a one year high of $113.00. The stock has a 50 day moving average price of $95.02 and a 200-day moving average price of $68.38.
Anterix (NASDAQ:ATEX – Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.43) by $0.44. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. The company had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $2.00 million. As a group, equities analysts predict that Anterix Inc. will post -2 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Stock Report on Anterix
Hedge Funds Weigh In On Anterix
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its position in shares of Anterix by 17.2% in the 1st quarter. Bank of America Corp DE now owns 167,781 shares of the company’s stock worth $6,408,000 after buying an additional 24,657 shares during the last quarter. GSA Capital Partners LLP raised its stake in shares of Anterix by 22.3% during the 4th quarter. GSA Capital Partners LLP now owns 72,976 shares of the company’s stock worth $1,593,000 after acquiring an additional 13,324 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Anterix during the second quarter valued at approximately $7,141,000. Kirr Marbach & Co. LLC IN lifted its position in Anterix by 13.3% during the first quarter. Kirr Marbach & Co. LLC IN now owns 113,814 shares of the company’s stock valued at $4,347,000 after acquiring an additional 13,396 shares during the last quarter. Finally, Waterfront Wealth Inc. boosted its stake in Anterix by 23.3% in the first quarter. Waterfront Wealth Inc. now owns 59,955 shares of the company’s stock valued at $2,290,000 after acquiring an additional 11,328 shares in the last quarter. Hedge funds and other institutional investors own 87.67% of the company’s stock.
About Anterix
Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.
At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.
Featured Stories
- Five stocks we like better than Anterix
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.
